Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enterobacteriaceae | 2 | 2019 | 8 | 1.030 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2019 | 13 | 1.030 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2021 | 2 | 0.680 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2021 | 3 | 0.680 |
Why?
|
| Myocarditis | 1 | 2021 | 4 | 0.680 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 109 | 0.630 |
Why?
|
| Fluoroquinolones | 1 | 2019 | 5 | 0.600 |
Why?
|
| Plasmids | 1 | 2019 | 17 | 0.590 |
Why?
|
| Raltegravir Potassium | 1 | 2016 | 2 | 0.500 |
Why?
|
| Drug Hypersensitivity Syndrome | 1 | 2016 | 3 | 0.500 |
Why?
|
| Eosinophilia | 1 | 2016 | 5 | 0.500 |
Why?
|
| beta-Lactamases | 1 | 2015 | 13 | 0.440 |
Why?
|
| Enterovirus Infections | 1 | 2013 | 2 | 0.400 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2013 | 3 | 0.400 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2013 | 3 | 0.400 |
Why?
|
| Molecular Typing | 1 | 2013 | 2 | 0.400 |
Why?
|
| Meningoencephalitis | 1 | 2013 | 3 | 0.400 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2013 | 10 | 0.400 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 17 | 0.400 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 30 | 0.390 |
Why?
|
| Child | 3 | 2019 | 339 | 0.350 |
Why?
|
| Child, Preschool | 3 | 2019 | 174 | 0.350 |
Why?
|
| Humans | 6 | 2021 | 5837 | 0.340 |
Why?
|
| Infant, Newborn | 3 | 2019 | 153 | 0.330 |
Why?
|
| Adolescent | 2 | 2021 | 488 | 0.280 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2019 | 10 | 0.260 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 24 | 0.250 |
Why?
|
| Infant | 2 | 2019 | 184 | 0.240 |
Why?
|
| Chicago | 2 | 2019 | 239 | 0.230 |
Why?
|
| Risk Factors | 2 | 2019 | 499 | 0.230 |
Why?
|
| Neutropenia | 1 | 2021 | 4 | 0.170 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 5 | 0.170 |
Why?
|
| Tachycardia | 1 | 2021 | 3 | 0.170 |
Why?
|
| Hypotension | 1 | 2021 | 6 | 0.170 |
Why?
|
| Bradycardia | 1 | 2021 | 10 | 0.170 |
Why?
|
| Fever | 1 | 2021 | 14 | 0.170 |
Why?
|
| Shock, Septic | 1 | 2021 | 13 | 0.170 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 62 | 0.170 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 31 | 0.170 |
Why?
|
| Male | 2 | 2021 | 3399 | 0.160 |
Why?
|
| Adult | 2 | 2015 | 1670 | 0.150 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 9 | 0.150 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 15 | 0.150 |
Why?
|
| Community-Acquired Infections | 1 | 2019 | 12 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2019 | 136 | 0.150 |
Why?
|
| Young Adult | 1 | 2019 | 421 | 0.130 |
Why?
|
| Female | 2 | 2016 | 3346 | 0.130 |
Why?
|
| Drug Eruptions | 1 | 2016 | 5 | 0.120 |
Why?
|
| Infection Control | 1 | 2015 | 27 | 0.110 |
Why?
|
| Enterovirus B, Human | 1 | 2013 | 2 | 0.100 |
Why?
|
| Ampicillin | 1 | 2013 | 3 | 0.100 |
Why?
|
| Molecular Epidemiology | 1 | 2013 | 3 | 0.100 |
Why?
|
| Pregnant Women | 1 | 2013 | 4 | 0.100 |
Why?
|
| Carrier State | 1 | 2013 | 11 | 0.100 |
Why?
|
| Gentamicins | 1 | 2013 | 13 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 34 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2013 | 94 | 0.100 |
Why?
|
| Pregnancy | 1 | 2013 | 103 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 38 | 0.100 |
Why?
|
| Time Factors | 1 | 2013 | 374 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2013 | 406 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2013 | 411 | 0.090 |
Why?
|